Facilitating a culture of responsible and effective sharing of cancer genome data

Rapid and affordable tumor molecular profiling has led to an explosion of clinical and genomic data poised to enhance the diagnosis, prognostication and treatment of cancer. A critical point has now been reached at which the analysis and storage of annotated clinical and genomic information in unconnected silos will stall the advancement of precision cancer care. Information systems must be harmonized to overcome the multiple technical and logistical barriers to data sharing. Against this backdrop, the Global Alliance for Genomic Health (GA4GH) was established in 2013 to create a common framework that enables responsible, voluntary and secure sharing of clinical and genomic data. This Perspective from the GA4GH Clinical Working Group Cancer Task Team highlights the data-aggregation challenges faced by the field, suggests potential collaborative solutions and describes how GA4GH can catalyze a harmonized data-sharing culture.

[1]  Russ B Altman,et al.  Genetics. Genomic research and human subject privacy. , 2004, Science.

[2]  B. Lo,et al.  Untapped potential: IRB guidance for the ethical research use of stored biological materials. , 2004, IRB.

[3]  Zhen Lin,et al.  Genomic Research and Human Subject Privacy , 2004, Science.

[4]  Sherri de Coronado,et al.  NCI Thesaurus: A semantic model integrating cancer-related clinical and molecular information , 2007, J. Biomed. Informatics.

[5]  G. Church,et al.  From genetic privacy to open consent , 2008, Nature Reviews Genetics.

[6]  S. Nelson,et al.  Resolving Individuals Contributing Trace Amounts of DNA to Highly Complex Mixtures Using High-Density SNP Genotyping Microarrays , 2008, PLoS genetics.

[7]  Jane Kaye,et al.  Sample, data use and protection in biobanking in Europe: legal issues. , 2008, Pharmacogenomics.

[8]  Susanne B Haga,et al.  Ethical, legal, and social implications of biobanks for genetics research. , 2008, Advances in genetics.

[9]  Wendy A. Wolf,et al.  The eMERGE Network: A consortium of biorepositories linked to electronic medical records data for conducting genomic studies , 2011, BMC Medical Genomics.

[10]  Elias Campo Guerri,et al.  International network of cancer genome projects , 2010 .

[11]  P. A. Kelly,et al.  To share or not to share: A randomized trial of consent for data sharing in genome research , 2011, Genetics in Medicine.

[12]  J. Mancini,et al.  Consent for biobanking: assessing the understanding and views of cancer patients. , 2011, Journal of the National Cancer Institute.

[13]  R. Gallagher,et al.  From consent to institutions: designing adaptive governance for genomic biobanks. , 2011, Social science & medicine.

[14]  Mark Walport,et al.  Sharing research data to improve public health , 2011, The Lancet.

[15]  Yann Joly,et al.  Data Sharing in the Post-Genomic World: The Experience of the International Cancer Genome Consortium (ICGC) Data Access Compliance Office (DACO) , 2012, PLoS Comput. Biol..

[16]  J. Kaye.  The tension between data sharing and the protection of privacy in genomics research. , 2012, Annual review of genomics and human genetics (Print).

[17]  Melissa A. Basford,et al.  Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data , 2013, Nature Biotechnology.

[18]  Carlos Caldas,et al.  The implications of clonal genome evolution for cancer medicine. , 2013, The New England journal of medicine.

[19]  D. Valle,et al.  PhenoDB: A New Web-Based Tool for the Collection, Storage, and Analysis of Phenotypic Features , 2013, Human mutation.

[20]  Michael Brudno,et al.  PhenoTips: Patient Phenotyping Software for Clinical and Research Use , 2013, Human mutation.

[21]  Yaniv Erlich,et al.  Routes for breaching and protecting genetic privacy , 2013 .

[22]  Eran Halperin,et al.  Identifying Personal Genomes by Surname Inference , 2013, Science.

[23]  E. Cuppen,et al.  Ethical, legal, and counseling challenges surrounding the return of genetic results in oncology. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  Bartha M. Knoppers,et al.  A human rights approach to an international code of conduct for genomic and clinical data sharing , 2014, Human Genetics.

[25]  Eric M Meslin,et al.  Building a data sharing model for global genomic research , 2014, Genome Biology.

[26]  J. Doroshow,et al.  Molecular analysis for therapy choice: NCI MATCH. , 2014, Seminars in oncology.

[27]  Masato Kimura,et al.  NCBI’s Database of Genotypes and Phenotypes: dbGaP , 2013, Nucleic Acids Res..

[28]  Damian Smedley,et al.  The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data , 2014, Nucleic Acids Res..

[29]  Sabine Tejpar,et al.  European perspective for effective cancer drug development , 2014, Nature Reviews Clinical Oncology.

[30]  E. Mardis,et al.  Prioritizing targets for precision cancer medicine. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  J. Bergh,et al.  A catalyst for change: the European cancer Patient's Bill of Rights. , 2014, The oncologist.

[32]  Deevakar Rogith,et al.  Attitudes regarding privacy of genomic information in personalized cancer therapy. , 2013, Journal of the American Medical Informatics Association : JAMIA.

[33]  R. Schilsky,et al.  Implementing personalized cancer care , 2014, Nature Reviews Clinical Oncology.

[34]  B. Knoppers.  International ethics harmonization and the global alliance for genomics and health , 2014, Genome Medicine.

[35]  C. Caldas,et al.  Cancer Core Europe: a consortium to address the cancer care-cancer research continuum challenge. , 2014, European journal of cancer.

[36]  Joshua M. Stuart,et al.  Global optimization of somatic variant identification in cancer genomes with a global community challenge , 2014, Nature Genetics.

[37]  Adam Kiezun,et al.  Whole-exome sequencing and clinical interpretation of FFPE tumor samples to guide precision cancer medicine , 2013, Nature Medicine.

[38]  D. Marsh,et al.  Factors that may influence the willingness of cancer patients to consent for biobanking. , 2014, Biopreservation and biobanking.

[39]  P. Johnston,et al.  A Bill of Rights for patients with cancer in Europe. , 2014, The Lancet. Oncology.

[40]  Richard L Schilsky,et al.  Building a rapid learning health care system for oncology: the regulatory framework of CancerLinQ. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  Dennis C. Friedrich,et al.  Whole-exome sequencing and clinical interpretation of formalin-fixed , paraffin-embedded tumor samples to guide precision cancer medicine , 2014 .

[42]  Thomas Bachelot,et al.  Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER). , 2014, The Lancet. Oncology.

[43]  Ash A. Alizadeh,et al.  Toward understanding and exploiting tumor heterogeneity , 2015, Nature Medicine.

[44]  Gil Alterovitz,et al.  All the World's a Stage: Facilitating Discovery Science and Improved Cancer Care through the Global Alliance for Genomics and Health. , 2015, Cancer discovery.

[45]  Robert C Green,et al.  GINA, genetic discrimination, and genomic medicine. , 2015, The New England journal of medicine.

[46]  Lior Pachter,et al.  The NIH BD2K center for big data in translational genomics , 2015, J. Am. Medical Informatics Assoc..

[47]  Peter N. Robinson,et al.  The Human Phenotype Ontology: Semantic Unification of Common and Rare Disease , 2015, American journal of human genetics.

[48]  Jan O. Korbel,et al.  Data analysis: Create a cloud commons , 2015, Nature.

[49]  Paolo Rocco,et al.  Good laboratory practice for clinical next-generation sequencing informatics pipelines , 2015 .

[50]  N. Siva.  UK gears up to decode 100 000 genomes from NHS patients , 2015, The Lancet.

[51]  S. Fröhling,et al.  Stakeholders’ perspectives on biobank-based genomic research: systematic review of the literature , 2015, European Journal of Human Genetics.

[52]  F. Collins,et al.  A new initiative on precision medicine. , 2015, The New England journal of medicine.

[53]  Joshua M. Stuart,et al.  Combining tumor genome simulation with crowdsourcing to benchmark somatic single-nucleotide-variant detection , 2015, Nature Methods.

[54]  Heidi L Rehm,et al.  ClinGen--the Clinical Genome Resource. , 2015, The New England journal of medicine.

[55]  Funda Meric-Bernstam,et al.  Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  M. McCarthy.  US president endorses “moonshot” effort to cure cancer , 2016, BMJ : British Medical Journal.

[57]  Denise L. Perry,et al.  Are physicians prepared for whole genome sequencing? a qualitative analysis , 2016, Clinical genetics.